2024Antiviral research234 : 106062
Host-targeting antivirals for chronic viral infections of the liver
Frericks N, Klöhn M, Lange F, Pottkämper L, Carpentier A, Steinmann E
Publikationen
2024Nature communications15 (1) : 1173
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
Sake S, Zhang X, Rajak M, Urbanek-Quaing M, Carpentier A, Gunesch A, Grethe C, Matthaei A, Rückert J, Galloux M, Larcher T, Le Goffic R, Hontonnou F, Chatterjee A, Johnson K, Morwood K, Rox K, Elgaher W, Huang J, Wetzke M, Hansen G, Fischer N, Eléouët J, Rameix-Welti M, Hirsch A, Herold E, Empting M, Lauber C, Schulz T, Krey T, Haid S, Pietschmann T
2023Liver international : official journal of the International Association for the Study of the Liver43 (10) : 2116-2129
Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell-derived hepatocytes
Lange F, Garn J, Anagho H, Vondran F, von Hahn T, Pietschmann T, Carpentier A
2020Gut69 (9) : 1659-1666
Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus
Carpentier A, Sheldon J, Vondran F, Brown R, Pietschmann T
2020PLoS pathogens16 (6) : e1008554
The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly
Vieyres G, Reichert I, Carpentier A, Vondran F, Pietschmann T